By upregulating the expression and activity of acid sphingomyelinase (aSMase), gentamicin altered sphingomyelin metabolism, resulting in increased apoptosis and reduced proliferation of gastric cancer cells in vitro [44]. The gene discussed is SMPD1; the disease is gastric cancer.